All products / DC9478
CDK9-IN-1
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $400 USDRequest a quote / confirm availability → |
| 250 mg | $800 USDRequest a quote / confirm availability → |
| 1 g | $1,600 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection. Among CDKs, CDK9 is a validated pathological target in HIV infection, inflammation and cardiac hypertrophy; however selective CDK9 inhibitors are still not available. We present a selective inhibitor family of CDK9 based on the 4-phenylamino-6- phenylpyrimidine nucleus. We show a convenient synthetic method to prepare a useful intermediate and its derivatisation resulting in novel compounds. The CDK9 inhibitory activity of the derivatives was measured in specific kinase assay and the CDK inhibitory profile of the best ones (IC50 > 100nM) was determined. The most selective compounds had high selectivity over CDK1, 2, 3, 5, 6, 7 and showed at least one order of magnitude higher inhibitory activity over CDK4 inhibition. The most selective molecules were examined in cytotoxicity assays and their ability to inhibit HIV-1 replication was determined in cellular assays.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC9478 |
|---|---|
| Product name | CDK9-IN-1 |
| CAS | 1415559-43-1 |
| Molecular formula | C26H21N5O4S |
| Molecular weight | 499.541 |
| Purity | >98% |
| SMILES | Cc1ccc(Nc2cc(-c3cccc(N4C(=O)c5ccccc5C4=O)c3)ncn2)cc1NS(C)(=O)=O |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — CDK9-IN-1 (DC9478)